LAG3 and neoplasm: Activation of LAG-3 can elevate intratumoral Tregs activity, and blocking of it will upregulate T-cell function and reinvigorate CD8+ tumor-infiltrating lymphocytes (TILs) to eliminate tumor cells (Lecocq et al., 2020).